{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:35:00Z","timestamp":1784255700399,"version":"3.55.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.clindermatol.2013.06.010","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T18:06:27Z","timestamp":1380305187000},"page":"555-563","source":"Crossref","is-referenced-by-count":24,"title":["Improved efficacy in onychomycosis therapy"],"prefix":"10.1016","volume":"31","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2013.06.010_bb0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1439-0507.2004.01090.x","article-title":"New insights into the effect of amorolfine nail lacquer","volume":"48","author":"Flagothier","year":"2005","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-4362.1999.00007.x","article-title":"Facing up to the diagnostic uncertainty and management of onychomycoses","volume":"38","author":"Arrese","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00128071-200102050-00002","article-title":"A plea to bridge the gap between antifungals and the management of onychomycosis","volume":"2","author":"Arrese","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0020","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1128\/AAC.47.10.3371-3372.2003","article-title":"Comparison of in vitro antifungal susceptibilities of conidia and hyphae of dermatophytes with thick-wall macroconidia","volume":"47","author":"Fern\u00e1ndez-Torres","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11046-011-9433-7","article-title":"Standardization of hyphal growth inhibition rate as a means of evaluating Microsporum spp. in vitro susceptibility to terbinafine, griseofulvin, and ciclopiroxolamine","volume":"172","author":"Biancalana","year":"2011","journal-title":"Mycopathologia"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0030","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.diagmicrobio.2011.08.007","article-title":"Susceptibility testing of terbinafine alone and in combination with amphotericin B, itraconazole, or voriconazole against conidia and hyphae of dematiaceous molds","volume":"71","author":"Biancalana","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/mmy.38.5.391.392","article-title":"The boosted antifungal topical treatment (BATT) for onychomycosis","volume":"38","author":"Pi\u00e9rard","year":"2000","journal-title":"Med Mycol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000018363","article-title":"The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen","volume":"200","author":"Pi\u00e9rard","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0045","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4103\/0378-6323.86475","article-title":"Onychomycosis: diagnosis and management","volume":"77","author":"Singal","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000073086","article-title":"Treatment failures and relapses in onychomycosis: a stubborn clinical problem","volume":"207","author":"Arrese","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/09546634.2012.703308","article-title":"Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment","volume":"24","author":"Gupta","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2133.1997.tb14902.x","article-title":"A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis","volume":"136","author":"Havu","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0065","article-title":"Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens","author":"Gupta","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000017990","article-title":"Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up","volume":"197","author":"Tosti","year":"1998","journal-title":"Dermatology (Basel)"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0075","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0733-8635(03)00026-3","article-title":"How to improve cure rates for the management of onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1067\/mjd.2001.110874","article-title":"Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly","volume":"44","author":"Gupta","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1468-3083.2008.03036.x","article-title":"The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis","volume":"23","author":"Gupta","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2133.2003.05728.x","article-title":"Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis","volume":"150","author":"Gupta","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.2001.145s60003.x","article-title":"The future of onychomycosis therapy may involve a combination of approaches","volume":"145","author":"Hay","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0100","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/archdermatol.2011.267","article-title":"A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index","volume":"147","author":"Carney","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0105","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.1997.tb14959.x","article-title":"Uncommon clinical patterns of Fusarium nail infection: report of three cases","volume":"136","author":"Baran","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-4362.1997.00024.x","article-title":"Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin","volume":"36","author":"Friedman-Birnbaum","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/myc.1990.33.4.167","article-title":"Treatment of onychomycosis with a bifonazole-urea combination","volume":"33","author":"Hardjoko","year":"1990","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0120","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-4362.1995.tb00625.x","article-title":"Efficacy and safety of bifonazole urea in the two-phase treatment of onychomycosis","volume":"34","author":"Bonifaz","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0125","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1346-8138.1998.tb02474.x","article-title":"Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study","volume":"25","author":"Syed","year":"1998","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0130","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archderm.1994.01690050022003","article-title":"Treatment of distal onychomycosis with avulsion and topical antifungal agents under occlusion","volume":"130","author":"Baden","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0135","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2340\/0001555567506510","article-title":"Hendersonula toruloidea infection: successful response of onychomycosis to nail avulsion and topical ciclopiroxolamine","volume":"67","author":"Rollman","year":"1987","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2230.1985.tb00597.x","article-title":"Partial surgical avulsion of the nail in onychomycosis","volume":"10","author":"Baran","year":"1985","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0145","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/09546634.2011.588191","article-title":"A comparative evaluation of combination therapy of fluconazole 1% and urea 40% compared with fluconazole 1% alone in a nail lacquer for treatment of onychomycosis: therapeutic trial","volume":"23","author":"Bassiri-Jahromi","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0150","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2133.2007.08014.x","article-title":"Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial","volume":"157","author":"Grover","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7547\/87507315-81-1-28","article-title":"Treatment of onychomycosis with nail avulsion and topical ketoconazole","volume":"81","author":"Hettinger","year":"1991","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000249920","article-title":"Treatment of onychomycosis by partial nail avulsion and topical miconazole","volume":"165","author":"Rollman","year":"1982","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0190-9622(00)90129-4","article-title":"Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases","volume":"42","author":"Tosti","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0170","first-page":"438","article-title":"Treatment of onychomycosis with ketoconazole and nonsurgical avulsion of the affected nail","volume":"31","author":"Moncada","year":"1983","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0175","first-page":"778","article-title":"Combined surgical and systemic treatment of onychomycosis","volume":"140","author":"Dominguez-Cherit","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/09546630050517207","article-title":"Combined treatment with surgery and short duration oral antifungal therapy in patients with limited dermatophyte toenail infection","volume":"11","author":"Goodfield","year":"2000","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0190","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7547\/0960465","article-title":"Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement IRON-CLAD, a large, randomized, open-label, multicenter trial","volume":"96","author":"Jennings","year":"2006","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjopharm.2005.12.012","article-title":"Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in Onychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial","volume":"4","author":"Tavakkol","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0185","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.jfas.2008.12.012","article-title":"Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial","volume":"48","author":"Malay","year":"2009","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0195","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/09546630600965004","article-title":"The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis","volume":"18","author":"Potter","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0205","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1365-2133.2000.03545.x","article-title":"A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region","volume":"142","author":"Baran","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0210","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0011-393X(02)80040-6","article-title":"An open-label, multicenter study of the combination of amorolfine nail lacquer and oral itraconazole compared with oral itraconazole alone in the treatment of severe toenail onychomycosis","author":"Lecha","year":"2002","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2133.2003.05381.x","article-title":"A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis","volume":"149","author":"Rigopoulos","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/09546630500420183","article-title":"Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis","volume":"16","author":"Avner","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0225","first-page":"481","article-title":"Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study","volume":"4","author":"Gupta","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0235","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/0378-6323.37056","article-title":"An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis","volume":"73","author":"Jaiswal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2133.2007.07974.x","volume":"157","author":"Baran","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0240","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1439-0507.2008.01531.x","article-title":"Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week)","volume":"52","author":"Takahata","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0245","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1346-8138.2006.00176.x","article-title":"Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study","volume":"33","author":"Nakano","year":"2006","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0250","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/09546630410035329","article-title":"Combination therapy consisting of week pulses of oral terbinafine plus topical application of terbinafine cream in the treatment of onychomycosis","volume":"15","author":"Sanmano","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0255","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2230.2009.03698.x","article-title":"In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis","volume":"35","author":"Bueno","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0260","first-page":"495","article-title":"Characterization of the antimicrobial susceptibility of fungi responsible for onychomycosis in Spain","volume":"49","author":"Zalacain","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0265","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2230.2007.02480.x","article-title":"In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium","volume":"32","author":"Sarifakioglu","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0270","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1365-4632.2007.03120.x","article-title":"Fusarium spp. as agents of onychomycosis in immunocompetent hosts","volume":"46","author":"Guilhermetti","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11046-007-9027-6","article-title":"Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections","volume":"164","author":"Figueiredo","year":"2007","journal-title":"Mycopathologia"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0280","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1099\/jmm.0.46542-0","article-title":"Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A)","volume":"56","author":"da Silva Barros","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0285","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijantimicag.2006.09.028","article-title":"Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment","volume":"29","author":"de Assis","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0290","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1139\/w05-100","article-title":"Determination of susceptibility\/resistance to antifungal drugs of Trichophyton mentagrophytes isolates by a macrodilution method","volume":"51","author":"da Silva Barros","year":"2005","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0295","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1468-3083.1998.tb00949.x","article-title":"Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs","volume":"11","author":"Torres-Rodr\u00edguez","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0300","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1067\/mjd.2001.110644","article-title":"Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis","volume":"44","author":"Gupta","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0305","first-page":"106","article-title":"Efficacy and safety of combination therapy with itraconazole and terbinafine to treat dermatophyte toenail onychomycosis","volume":"1","author":"Gupta","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0310","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1517\/17425240802497218","article-title":"Enhancing the nail permeability of topically applied drugs","volume":"5","author":"Murdan","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.10.002","article-title":"Transungual drug delivery: current status","volume":"384","author":"Elkeeb","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0320","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/03639045.2011.637931","article-title":"Ungual and transungual drug delivery","volume":"38","author":"Shivakumar","year":"2012","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0325","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(02)00321-6","article-title":"Nail morphology studies as assessments for onychomycosis treatment modalities","volume":"245","author":"Repka","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0330","first-page":"363","article-title":"Structural characteristics and permeability properties of the human nail: a review","volume":"50","author":"Gupchup","year":"1999","journal-title":"J Cosmet Sci"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0335","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/03639040600683410","article-title":"Influence of tartaric acid on the bioadhesion and mechanical properties of hot-melt extruded hydroxypropyl cellulose films for the human nail","volume":"32","author":"Mididoddi","year":"2006","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0340","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/03639045.2010.491832","article-title":"A platform for predicting and enhancing model drug delivery across the human nail plate","volume":"37","author":"Vaka","year":"2011","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0345","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2004.06.010","article-title":"Influence of human nail etching for the assessment of topical onychomycosis therapies","volume":"282","author":"Repka","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0350","author":"Boker"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0355","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0190-9622(96)80069-7","article-title":"Physical enhancement of dermatologic drug delivery: iontophoresis and phonophoresis","volume":"34","author":"Kassan","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0360","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.7863\/jum.2011.30.12.1723","article-title":"Ultrasound-mediated nail drug delivery system","volume":"30","author":"Abadi","year":"2011","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0365","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/17425247.2012.642364","article-title":"Iontophoretic drug delivery across the nail","volume":"9","author":"Delgado-Charro","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0370","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1002\/jps.21711","article-title":"Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis","volume":"98","author":"Nair","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0375","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3109\/03639045.2011.568946","article-title":"Transungual delivery of terbinafine by iontophoresis in onychomycotic nails","volume":"37","author":"Nair","year":"2011","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0380","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/jps.21555","article-title":"Trans-ungual iontophoretic delivery of terbinafine","volume":"98","author":"Nair","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0385","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2133.2009.09414.x","article-title":"Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study","volume":"162","author":"Amichai","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0390","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2012.06.020","article-title":"Hydration of nail plate: a novel screening model for transungual drug permeation enhancers","volume":"436","author":"Chouhan","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0395","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1002\/jps.21743","article-title":"TranScreen-NTM: method for rapid screening of trans-ungual drug delivery enhancers","volume":"98","author":"Murthy","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0400","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1211\/jpp.62.06.0009","article-title":"Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents","volume":"62","author":"Traynor","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0405","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.11.009","article-title":"Overcoming the nail barrier: a systematic investigation of ungual chemical penetration enhancement","volume":"370","author":"Brown","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0410","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2009.03164.x","article-title":"An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis","volume":"23","author":"Baran","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0415","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1081\/DDC-43935","article-title":"In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer","volume":"31","author":"Monti","year":"2005","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0420","doi-asserted-by":"crossref","first-page":"e38181","DOI":"10.1371\/journal.pone.0038181","article-title":"Cytoplasmic fungal lipases release fungicides from ultra-deformable vesicular drug carriers","volume":"7","author":"Steinberg","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0425","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1128\/JCM.00083-11","article-title":"Activity of TDT 067 (terbinafine in Transfersome) against agents of onychomycosis, as determined by minimum inhibitory and fungicidal concentrations","volume":"49","author":"Ghannoum","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0430","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1365-2133.2011.10766.x","article-title":"Open\u2010label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome\u00ae) in patients with onychomycosis","volume":"166","author":"Dominicus","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0435","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpharm.2010.06.051","article-title":"Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro","volume":"397","author":"Vejnovic","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0440","first-page":"189","article-title":"Onychomycosis: strategies to reduce failure and recurrence","volume":"62","author":"Gupta","year":"1998","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0445","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7547\/1020309","article-title":"Optimization of an infected shoe model for the evaluation of an ultraviolet shoe sanitizer device","volume":"102","author":"Ghannoum","year":"2012","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0450","doi-asserted-by":"crossref","DOI":"10.3109\/09546634.2012.714456","article-title":"Ozone gas effectively kills laboratory strains of Trichophyton rubrum and Trichophyton mentagrophytes using an in vitro test system","author":"Gupta","year":"2012","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0455","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2310\/7750.2012.12068","article-title":"Sanitization of contaminated footwear from onychomycosis patients using ozone gas: a novel adjunct therapy for treating onychomycosis and tinea pedis?","volume":"17","author":"Gupta","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2013.06.010_bb0460","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1468-3083.2009.03547.x","article-title":"Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years","volume":"24","author":"Sigurgeirsson","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13001399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13001399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T06:03:09Z","timestamp":1716012189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X13001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0738081X13001399"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2013.06.010","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}